ASCO GI: Oral Chemo S-1 Increases Survival in Pancreatic Cancer, Japanese Study Shows

An oral fluoropyrimidine, S-1, used as an adjuvant therapy in Japanese patients with resected pancreatic cancer has shown an improved overall survival compared with the standard adjuvant therapy gemcitabine (Gemzar).
Source: Cancer Network - Category: Cancer & Oncology Source Type: news